Immunological and functional differences between human type I and II colony-stimulating factors

M. C. Wu, A. M. Miller, Adel A Yunis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Two distinct types of colony-stimulating factor (CSF) have recently been described in human tissues and cultured cell lines. Antisera to purified type I and II CSF were prepared in rabbits. Anti-CSF I antibody inhibits CSF I, but has no effect on CSF II. It cross-inhibits CSF I from several other human sources, but does not inhibit CSF from mouse lung or mouse L cells. Anti-CSF II antibody inhibits the activity of CSF II, but has no effect on CSF I. A radioimmunoassay for CSF I has been established. Competitive binding assay further demonstrated the immunological differences between CSF I and II. When CSF II is used to stimulate human marrow cells fractionated by sedimentation velocity, two populations of CFU-C are separated, one sedimenting at 8 mm/h and forming colonies by day 7, and a second sedimenting at 6.8 mm/h and forming colonies by day 13. In contrast, CSF I does not stimulate colony growth by day 7 but does do so by day 13 in cells sedimenting between 7.2-8.5 mm/h. These results indicate that CSF I and II are distinct in their biochemical, immunological, and functional properties.

Original languageEnglish (US)
Pages (from-to)1588-1591
Number of pages4
JournalJournal of Clinical Investigation
Volume67
Issue number5
StatePublished - 1981

Fingerprint

Colony-Stimulating Factors
Competitive Binding
Antibodies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Immunological and functional differences between human type I and II colony-stimulating factors. / Wu, M. C.; Miller, A. M.; Yunis, Adel A.

In: Journal of Clinical Investigation, Vol. 67, No. 5, 1981, p. 1588-1591.

Research output: Contribution to journalArticle

Wu, M. C. ; Miller, A. M. ; Yunis, Adel A. / Immunological and functional differences between human type I and II colony-stimulating factors. In: Journal of Clinical Investigation. 1981 ; Vol. 67, No. 5. pp. 1588-1591.
@article{057caa888a704e208cedbef25554615c,
title = "Immunological and functional differences between human type I and II colony-stimulating factors",
abstract = "Two distinct types of colony-stimulating factor (CSF) have recently been described in human tissues and cultured cell lines. Antisera to purified type I and II CSF were prepared in rabbits. Anti-CSF I antibody inhibits CSF I, but has no effect on CSF II. It cross-inhibits CSF I from several other human sources, but does not inhibit CSF from mouse lung or mouse L cells. Anti-CSF II antibody inhibits the activity of CSF II, but has no effect on CSF I. A radioimmunoassay for CSF I has been established. Competitive binding assay further demonstrated the immunological differences between CSF I and II. When CSF II is used to stimulate human marrow cells fractionated by sedimentation velocity, two populations of CFU-C are separated, one sedimenting at 8 mm/h and forming colonies by day 7, and a second sedimenting at 6.8 mm/h and forming colonies by day 13. In contrast, CSF I does not stimulate colony growth by day 7 but does do so by day 13 in cells sedimenting between 7.2-8.5 mm/h. These results indicate that CSF I and II are distinct in their biochemical, immunological, and functional properties.",
author = "Wu, {M. C.} and Miller, {A. M.} and Yunis, {Adel A}",
year = "1981",
language = "English (US)",
volume = "67",
pages = "1588--1591",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "5",

}

TY - JOUR

T1 - Immunological and functional differences between human type I and II colony-stimulating factors

AU - Wu, M. C.

AU - Miller, A. M.

AU - Yunis, Adel A

PY - 1981

Y1 - 1981

N2 - Two distinct types of colony-stimulating factor (CSF) have recently been described in human tissues and cultured cell lines. Antisera to purified type I and II CSF were prepared in rabbits. Anti-CSF I antibody inhibits CSF I, but has no effect on CSF II. It cross-inhibits CSF I from several other human sources, but does not inhibit CSF from mouse lung or mouse L cells. Anti-CSF II antibody inhibits the activity of CSF II, but has no effect on CSF I. A radioimmunoassay for CSF I has been established. Competitive binding assay further demonstrated the immunological differences between CSF I and II. When CSF II is used to stimulate human marrow cells fractionated by sedimentation velocity, two populations of CFU-C are separated, one sedimenting at 8 mm/h and forming colonies by day 7, and a second sedimenting at 6.8 mm/h and forming colonies by day 13. In contrast, CSF I does not stimulate colony growth by day 7 but does do so by day 13 in cells sedimenting between 7.2-8.5 mm/h. These results indicate that CSF I and II are distinct in their biochemical, immunological, and functional properties.

AB - Two distinct types of colony-stimulating factor (CSF) have recently been described in human tissues and cultured cell lines. Antisera to purified type I and II CSF were prepared in rabbits. Anti-CSF I antibody inhibits CSF I, but has no effect on CSF II. It cross-inhibits CSF I from several other human sources, but does not inhibit CSF from mouse lung or mouse L cells. Anti-CSF II antibody inhibits the activity of CSF II, but has no effect on CSF I. A radioimmunoassay for CSF I has been established. Competitive binding assay further demonstrated the immunological differences between CSF I and II. When CSF II is used to stimulate human marrow cells fractionated by sedimentation velocity, two populations of CFU-C are separated, one sedimenting at 8 mm/h and forming colonies by day 7, and a second sedimenting at 6.8 mm/h and forming colonies by day 13. In contrast, CSF I does not stimulate colony growth by day 7 but does do so by day 13 in cells sedimenting between 7.2-8.5 mm/h. These results indicate that CSF I and II are distinct in their biochemical, immunological, and functional properties.

UR - http://www.scopus.com/inward/record.url?scp=0019485003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019485003&partnerID=8YFLogxK

M3 - Article

C2 - 6971879

AN - SCOPUS:0019485003

VL - 67

SP - 1588

EP - 1591

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 5

ER -